Page last updated: 2024-11-08

4-nitroquinoline-1-oxide and Lupus Erythematosus, Systemic

4-nitroquinoline-1-oxide has been researched along with Lupus Erythematosus, Systemic in 1 studies

4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vasil'eva, IM1
Lisitsina, TA1
Durnev, AD1
Ivanova, MM1
Zasukhina, GD1

Other Studies

1 other study available for 4-nitroquinoline-1-oxide and Lupus Erythematosus, Systemic

ArticleYear
[Comparative study of DNA-repair ability of lymphocytes from systemic lupus erythematosus and rheumatoid arthritis patients].
    Genetika, 1997, Volume: 33, Issue:12

    Topics: 4-Nitroquinoline-1-oxide; Arthritis, Rheumatoid; Chromatography, Liquid; DNA Damage; DNA Repair; Hum

1997